Trials (Karolinska Institute and University Hospital): Revision history

15 December 2025

• curprev 16:4416:44, 15 December 2025‎ Francine talk contribs‎ 182,953 bytes +223‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 182,730 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:0117:01, 4 December 2025‎ Larysse talk contribs‎ 181,029 bytes +48‎ No edit summary undo

2 December 2025

• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 180,981 bytes +90‎ Update categories. undo

5 December 2023

• curprev 17:3517:35, 5 December 2023‎ Francine talk contribs‎ 180,891 bytes +180,891‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Karolinska Institute and University Hospital page '''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in..."